Elizabeth A Bramhall

Title: Elizabeth A Bramhall: Innovator in Recombinant Protein Production

Introduction

Elizabeth A Bramhall is a prominent inventor based in Groton, MA (US). She has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. With a total of 5 patents to her name, her work has had a substantial impact on medical research and therapeutic development.

Latest Patents

Among her latest patents, one notable invention is focused on compositions and methods for producing a composition. This invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. It also includes compositions comprising CTLA4-Ig and formulations thereof. Furthermore, the invention outlines methods for mass-producing CTLA4-Ig from mammalian cells and for purifying the CTLA4-Ig. Another patent addresses the carbohydrate content of CTLA4 molecules, reinforcing her expertise in this area.

Career Highlights

Elizabeth A Bramhall has established herself as a key figure in her field through her innovative work at Bristol-Myers Squibb Company. Her research has contributed to advancements in therapeutic proteins, which are crucial for various medical applications.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Kirk J Leister and Eugene J Schaefer. These partnerships have further enhanced her research and development efforts.

Conclusion

Elizabeth A Bramhall's contributions to biotechnology and her innovative patents underscore her role as a leading inventor in the field. Her work continues to influence the development of recombinant proteins, paving the way for future advancements in medical therapies.